Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06944925 · ClinicalTrials.gov registry record · Phase 1
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
A Phase 1 study, sponsored by Bambusa Therapeutics.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 286
- Enrollment target
NCT06944925: Recruiting Phase 1 study, sponsored by Bambusa Therapeutics.
NCT06944925 is a Phase 1 study that is actively recruiting participants, run by Bambusa Therapeutics. The registered enrollment target is 286 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (377% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06944925, a Phase 1 study, is actively recruiting participants, sponsored by Bambusa Therapeutics.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 286 participants
- Enrollment target
Study Summary
Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).
Primary Outcome
Incidence, relatedness, and severity of adverse events (AEs) graded per CTCAE v6.0.
Interventions
- DRUG Placebo
- DRUG BBT002
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 286 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2027-07-31 |
| Phase | Phase 1 |
What NCT06944925 shows while recruiting
NCT06944925 is an interventional study that assigns participants to a tested intervention. The registered 286 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (377% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06944925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06944925 about?
NCT06944925 is a clinical study titled "A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)". Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).
What is the current status of trial NCT06944925?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 286 participants. The study started on 2025-05-08. Estimated completion is 2027-07-31.
What interventions are being tested in trial NCT06944925?
The interventions under investigation include: Placebo (DRUG), BBT002 (DRUG).
Who is sponsoring clinical trial NCT06944925?
This trial is sponsored by Bambusa Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06944925's enrollment target sits among peer trials
286 139th of 2000 higher than 1,862 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04781140 · 286 participants · Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- NCT04936529 · 286 participants · Phase 2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- NCT05183646 · 286 participants · Phase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- NCT05506878 · 286 participants · NA
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI